|
81 |
Kommentar der Multiple Sklerose Therapie Konsensus Gruppe (MSTKG) zur S2k-Leitlinie Multiple Sklerose
Enthalten in DGNeurologie Bd. 4, 16.6.2021, Nr. 4, date:7.2021: 319-326
|
|
|
|
82 |
Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis
Enthalten in Nature neuroscience Bd. 21, 26.9.2018, Nr. 10, date:10.2018: 1392-1403
|
|
|
|
83 |
Meilenstein oder verpasste Chance?
Enthalten in Der Nervenarzt Bd. 90, 7.2.2019, Nr. 2, date:2.2019: 183-184
|
|
|
|
84 |
Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions
Enthalten in Neurological research and practice Bd. 3, 6.8.2021, Nr. 1, date:12.2021: 1-7
|
|
|
|
85 |
Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper)
Enthalten in Der Nervenarzt Bd. 92, 23.7.2021, Nr. 8, date:8.2021: 773-801
|
|
|
|
86 |
Network alterations underlying anxiety symptoms in early multiple sclerosis
Enthalten in Journal of neuroinflammation Bd. 19, 24.5.2022, Nr. 1, date:12.2022: 1-13
|
|
|
|
87 |
Preventing disease progression in multiple sclerosis—insights from large real-world cohorts
Enthalten in Genome medicine Bd. 14, 20.4.2022, Nr. 1, date:12.2022: 1-3
|
|
|
|
88 |
Publisher Correction: Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis
Enthalten in Nature neuroscience Bd. 22, 7.11.2018, Nr. 1, date:1.2019: 144
|
|
|
|
89 |
Spatial transcriptomics and neurofilament light chain reveal changes in lesion patterns in murine autoimmune neuroinflammation
Enthalten in Journal of neuroinflammation Bd. 20, 13.11.2023, Nr. 1, date:12.2023: 1-17
|
|
|
|
90 |
Targeting prohibitins at the cell surface prevents Th17‐mediated autoimmunity
Enthalten in European Molecular Biology Organization: The EMBO journal Bd. 37, 26.07.2018, Nr. 16, date:08.2018: 1-14
|
|
Administration
